NO954806L - Anvendelse av lignanderivater ved fremstilling av farmasöytiske preparater for behandling av amyloidosetilstander - Google Patents

Anvendelse av lignanderivater ved fremstilling av farmasöytiske preparater for behandling av amyloidosetilstander

Info

Publication number
NO954806L
NO954806L NO954806A NO954806A NO954806L NO 954806 L NO954806 L NO 954806L NO 954806 A NO954806 A NO 954806A NO 954806 A NO954806 A NO 954806A NO 954806 L NO954806 L NO 954806L
Authority
NO
Norway
Prior art keywords
preparation
treatment
pharmaceutical compositions
lignan derivatives
amyloidosis
Prior art date
Application number
NO954806A
Other languages
English (en)
Other versions
NO954806D0 (no
NO308883B1 (no
Inventor
Borje Rosen
Kurt Leander
Original Assignee
Conpharm Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conpharm Ab filed Critical Conpharm Ab
Publication of NO954806D0 publication Critical patent/NO954806D0/no
Publication of NO954806L publication Critical patent/NO954806L/no
Publication of NO308883B1 publication Critical patent/NO308883B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO954806A 1993-05-28 1995-11-27 Anvendelse av lignanderivater ved fremstilling av farmasøytiske preparater for behandling av amyloidosetilstander NO308883B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939301831A SE9301831D0 (sv) 1993-05-28 1993-05-28 Pharmaceutical compositions
PCT/SE1994/000493 WO1994027614A1 (en) 1993-05-28 1994-05-25 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis

Publications (3)

Publication Number Publication Date
NO954806D0 NO954806D0 (no) 1995-11-27
NO954806L true NO954806L (no) 1996-01-26
NO308883B1 NO308883B1 (no) 2000-11-13

Family

ID=20390089

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954806A NO308883B1 (no) 1993-05-28 1995-11-27 Anvendelse av lignanderivater ved fremstilling av farmasøytiske preparater for behandling av amyloidosetilstander

Country Status (15)

Country Link
US (1) US5637571A (no)
EP (1) EP0700296A1 (no)
JP (1) JPH09505270A (no)
CN (1) CN1126947A (no)
AU (1) AU694431B2 (no)
BR (1) BR9406655A (no)
CA (1) CA2163887A1 (no)
CZ (1) CZ285590B6 (no)
HU (1) HUT73812A (no)
NO (1) NO308883B1 (no)
RU (1) RU2148407C1 (no)
SE (1) SE9301831D0 (no)
SK (1) SK280005B6 (no)
UA (1) UA41367C2 (no)
WO (1) WO1994027614A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4677496A (en) * 1995-02-21 1996-09-11 Takeda Chemical Industries Ltd. Use of helioxanthin as an enhancer of cell differentiation inducing factors
WO1997026919A2 (en) * 1996-01-24 1997-07-31 Warner-Lambert Company Method of imaging amyloid deposits
KR100416120B1 (ko) * 1997-11-15 2004-05-07 동화약품공업주식회사 천연물로부터 분리한 신규 리그난계통의 항종양 물질
CU20130027A7 (es) 2013-02-28 2014-10-30 Ct De Neurociencias De Cuba Chaperoninas químicas como nuevos moduladores moleculares de la beta agregación proteica presente en las enfermedades conformacionales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB823068A (en) * 1955-05-13 1959-11-04 Sandoz Ltd Condensation products from glucosides
DE3584370D1 (de) * 1984-12-28 1991-11-14 Conpharm Ab Verwendung von podophyllotoxin und dessen derivaten.

Also Published As

Publication number Publication date
EP0700296A1 (en) 1996-03-13
HUT73812A (en) 1996-09-30
NO954806D0 (no) 1995-11-27
AU6939894A (en) 1994-12-20
JPH09505270A (ja) 1997-05-27
SK146495A3 (en) 1996-06-05
AU694431B2 (en) 1998-07-23
SK280005B6 (sk) 1999-07-12
NO308883B1 (no) 2000-11-13
UA41367C2 (uk) 2001-09-17
BR9406655A (pt) 1996-03-19
CA2163887A1 (en) 1994-12-08
CZ285590B6 (cs) 1999-09-15
WO1994027614A1 (en) 1994-12-08
HU9503351D0 (en) 1996-01-29
SE9301831D0 (sv) 1993-05-28
CN1126947A (zh) 1996-07-17
CZ310695A3 (en) 1996-04-17
US5637571A (en) 1997-06-10
RU2148407C1 (ru) 2000-05-10

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
IL99183A0 (en) Water soluble derivatives of taxol,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ238545A (en) Dialkoxy-pyridinyl-benzimidazole derivatives; preparation and pharmaceutical compositions thereof
HUP0001192A3 (en) The use of topiramate and its derivatives for the preparation of pharmaceutical compositions treating obesity
NZ255505A (en) Substituted thiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
HUP0001267A3 (en) Use of rapamycin derivatives for the preparation of pharmaceutical compositions treating vasculopathies
EE03177B1 (et) Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid
GB9206736D0 (en) Improvements of organic compounds and their use in pharmaceutical compositions
BR9604632A (pt) Compostos bicíclicos aromáticos utilizaçao de pelo menos um dos compostos composiçao farmacêutica composiçao cosmética e utilizaçao de uma composiçao cosmética
HUP9901326A3 (en) Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions
IT1297205B1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
ITMI910456A0 (it) Composizione farmaceutica per il trattamento della cataratta
IL105406A (en) Derivatives of adipogenesis inhibitory factor processes for the preparation thereof and pharmaceutical compositions containing the same
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
NO954806D0 (no) Anvendelse av lignanderivater ved fremstilling av farmasöytiske preparater for behandling av amyloidosetilstander
HU0500865D0 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
IL115981A0 (en) Cyclolignan derivatives procosses for the preparation thereof and pharmaceutical compositions containing the same
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IT1277117B1 (it) Composizioni farmaceutiche per il trattamento delle ipercolesterolemie
IL99236A0 (en) Pharmaceutical composition for the topical treatment of psoriasis
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2003